Improvement in the survival of victims after a major nuclear accident

Most countermeasures for lethal radiation damage require administration of the product before the irradiation event, which is highly impractical. Our product has shown that it can be administered after the irradiation event and it can improve survival from 5% in the control group to 60% in the treatment group, a remarkable 1200% over baseline.